ロード中...
The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis
Radical cure of Plasmodium vivax malaria in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals employs weekly primaquine dosing. This is the only recommended regimen for this patient sub-group. If national malaria programs mandate daily primaquine dosing (the recommended regimen for G6PD...
保存先:
| 出版年: | Wellcome Open Res |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
F1000 Research Limited
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6480970/ https://ncbi.nlm.nih.gov/pubmed/31069260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/wellcomeopenres.15100.2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|